Chinese materia medica (CMM) is becoming increasingly important in modern health care, with the potential for new or improved clinical protocols and reduction in treatment costs. Conventional approaches to drug discovery are based on knowledge of biological systems and screen phenotypes in the context of a whole organism. It will be valuable to identify the CMM that would induce certain biological responses (such as angiogenesis). The authors have developed a database that they plan to commercialize that contains traditional knowledge of Chinese medicine and pharmacology along with their own experimental data from controlled scientific observations by using the zebrafish as a model of CMM-induced pathology. The database is visualized and functions via the World Wide Web by subscription or license. The authors have also written software for personal digital assistant (PDA) devices that supports multiple users performing screening experiments worldwide. This provides a platform for the study of CMM, and data mining of this resource will help evaluate CMM in the context of experimental observations of biological aberrations. (Journal of Biomolecular Screening 2008:390-395) 
INTRODUCTION
T HE DISCOVERY OF PHARMACOLOGICAL ACTIVITIES starts with the identification of biological targets that are believed to be connected to a particular disease state or pathology. 1 Many Chinese materia medica (CMM) clearly contains natural products of therapeutic value and, as a consequence, is becoming increasingly important in modern health care. 2, 3 Recently, the zebrafish has become a model organism for drug target discovery, target validation, drug-finding strategies, and toxicological studies. On average, zebrafish proteins display less than 70% identity to their human orthologs. 1 However, conservation of functional domains, such as active sites, is considerably higher, consistent with observations that many drugs elicit effects in zebrafish comparable to those in humans. 1, 4 Application of many drugs to the zebrafish is simple, as embryos rapidly absorb low molecular weight compounds, diluted in the surrounding media, through the skin and gills. 1, 4 Zebrafish-based drug screening allows high-throughput analysis with significant relevance to humans. 1, [4] [5] [6] [7] Screening angiogenic modulating activities by using zebrafish embryos is a well-known experimental technique. 6 Angiogenesis is a biological process that supports and controls the growth of new blood vessels. It is believed that abnormal angiogenesis is associated with cancer, coronary artery disease, and numerous other diseases. In angiogenesis, endothelial cells within an existing vessel are activated to divide and secrete enzymes that cause localized damage and the subsequent extension of a new vessel. 8 Databases are available for all aspects of traditional Chinese medicine (TCM), 9, 10 for example, Chinese medicinal plants and constituent chemicals, 11 CMM toxicology, 12 and 3D structure of CMM. 13 Integration of the available TCM data is useful for scientific evaluations, especially information on CMM, such as herbs, herbal formulas and their chemical components, molecular structures, and therapeutic effects. In drug screening or discovery, it is necessary to combine data from various scientific disciplines 14 so that decisions or solutions can be generated from massive volumes of data. [15] [16] [17] Data mining that integrates CMM data and scientific investigations may be a valuable adjunct in supporting decisions.
In this article, a computer system that supports data mining by combining current scientific research data with existing knowledge will be reported. An illustration of our own zebrafish experiments, designed to screen the effects of CMM, is used. Our system offers 3 visualizations to allow users to study the relationships between different CMM and access data-mining results by surfing the Internet.
DESCRIPTION OF DATA

Experimental data
Experiments were performed to determine the types of CMM that affected angiogenesis. Known combinations of herbs (herbal formulas), herbs, or chemicals from herbs that are used in CMM were tested individually against the biological targets (zebrafish). Classic Chinese herbal formulas were used, in which particular types and proportions of herbs were defined. The formulas and herbs used in this screening have been refined through modern industrial methods of extraction, condensation, drying, and granule shaping.
Vascular endothelial cells were assayed by the presence of endogenous alkaline phosphatase activity. The basic parameters measured were the absence or presence of intersegmental vessels (ISVs) and pericardial edema, as well as the normality or abnormality of body development. Microscopic images of the transparent zebrafish embryo were recorded. All observations of each living embryo and the number of dead embryos for each concentration of CMM were recorded. Each zebrafish embryo had its own record. Approximately 20,000 records were generated by the screening experiments during the course of 1 year. All data were recorded through our software into a personal digital assistant (PDA) during the screening experiments and subsequently transferred to a database in Microsoft Access (MS Access), which provided a simple format of electronic storage.
Information on CMM
Data relating to the selected CMM were collected from books [18] [19] [20] [21] [22] [23] to build the database. A set of 109 herbs was obtained, and a serial number, as well as Latin (see below), Chinese, Pinyin, and botanical names of the herb and its target treatment, was collected for each herb or herbal part. Latin names were constructed by using a part of the plant and the genus and/or species names, for example, Radix Ginseng, which has the botanical name Panax ginseng C.A. Mey. The unique Latin name of the herb or herbal part was used to assign serial numbers. All data were validated by referencing the Pharmacopoeia of the People's Republic of China, 23 where information on 15 formulas, 150 herbs (or herbal parts), and 1500 chemical compounds were stored.
DATABASE DESIGN AND IMPLEMENTATION
A database was developed by storing the information from experimental data and traditional knowledge in a tabular format. Records were directly entered, edited, and corrected into tables in a database. The database (CMBank) was created with MS Access and can be searched by using various parameters through the built-in interface to retrieve information. The maximum capacity of MS Access is 2 gigabytes. The current size of the CMBank is 8 megabytes, which does not affect performance. There were 8 interrelated tables: HERB, Cpd (compound), Fma (formula), FMAHERB (formula's herbs), HERBCPD (compounds in an herb), Tsn (treatment), ID (identification), and Exp (experiment). The schema of the 8 tables in the database is illustrated in Figure  1 and shows the fields of each table and the common fields that link them. Structured Query Language (SQL) was used for querying and updating data. Figure 2 illustrates a model of the relationships among the herbs, formulas, and compound tables after data integration.
WEB INTERFACES VIA THE WORLD WIDE WEB (WWW)
To access the information in the database, a Web-based display system using Microsoft's Internet Server Application Program Interface was developed. Active Server Pages (ASPs) were written in Visual Basic script (VBScript). The Web application described in this article is structured as a 3-tiered model. 24, 25 In the first tier, the Web browser requests input and displays the response. The Web server provides the middle tier and queues all requests and generates responses that will be displayed as Web pages. The database or third tier generates the results, which will be sent to the Web server.
Three methods (a database browser, answer tree, screening result) to visualize data from queries were established. The user is asked to choose one of the methods.
A database browser allowed for 5 kinds of questions to be answered from the database, as shown in Figure 3 . If a formula name was selected, the components of that formula and names of all the relevant herbs were displayed ( Fig. 3a) . For an herb query, information on the herb was displayed with 2 links to show the chemical components or the different formulas that contained the particular herb ( Fig. 3b) . A compound name query would show information on the chemical with links to herbs that contained it ( Fig. 3c ). Chemical compounds found in an herb could be shown (Fig. 3d) , and different formulas that shared a common herb could be found (Fig. 3e) .
The Answer Tree displayed the name of the CMM of interest in a hierarchical structure. It used the linkages of the tables to allow all the information belonging to a formula to be shown on the same page. For example, when a formula was selected, the complete record was displayed. Herbs or chemical components that belonged to the formula were shown.
Screening experimental results can be retrieved and displayed based on the name of the CMM of interest.
DISCUSSION
Deriving knowledge from data mining
CMM is intended to treat underlying conditions that are diagnosed by traditional methods. 18 Usually, different herbs will be mixed to form formulas for specific treatments, and 1 herb may be used in several formulas (e.g., Fig. 3e ). Most people in China and many worldwide have used CMM for different stages of disease, for instance, by taking nonprescription drugs that are available in herbal pharmacies.
Identifying the components of CMM can be difficult as most CMM sold in markets and shops has been processed; for example, it may be sun dried or sliced, or the seeds are taken out from the fruit. Further confusion occurs as the herbs used may have several common names as well as their botanical name. Whether the herbs are dried or fresh, they may be sold as whole plants or part of the plant, such as the fruit, leaves, branches, or roots. Importantly, parts of the same plant may have different therapeutic uses; for example, Gui Zhi and Rou Gui belong to the same plant, Cinnamomum cassia, 19 but are different therapeutic agents. Therefore, it is necessary to identify which plant and part of the plant is the origin of the herbal medical agent. Herbal agents used in TCM are named according to the part of the plant and the genus or/and species names, for example, Radix Ginseng, which has the botanical name Panax ginseng C.A. Mey.
Western tradition tends to focus heavily on the biochemical constituents of plants to explain their physiological actions. Certain herbs contain significant amounts of a small number of potent chemicals. 3, 16, 20, 21 The net physiological action of herbs, such as Radix Ginseng and Radix Rehmanniae, is more difficult to explain biochemically because they contain a large number of nutrients and physiologically active chemicals. In TCM, herbs are extensively used clinically before the complex chemistry of their components can be understood. The pharmacological properties of herbs or formulas also vary, in accordance to the time, conditions, and age at the harvesting of the plants. In addition, the method of extraction, time, temperature, and vigor of extraction may also affect the potency. In collections of herbs and associated data, the methods and conditions ID table; Conc field, the concentration of CMM in the culture medium; Date, the time stamp of each entry in the screening; Mal field, which states if the embryo was malformed; Ede field, if the embryo had pericardial edema; Trk field, if the intersegmental vessel (ISV) was absent in the trunk part of the embryo; Tail field, if the ISV was absent in the tail part of the embryo; Abr field, which is the comment on the ISV; Art field, if the caudal artery was absent; Vein field, if the caudal vein was absent; SIV field, which is the comment on the subintestinal vessels; and Other, which is a comment on the embryo (e.g., the number of ISV missing). ID table The ID table connects other tables. It has FmaID from the  Fma table, HbID from the HERB table, CpdID from the Cpd table,  ExpID from the Exp table, of storage should be noted, as these may affect an extract's potency due to potential liability of active components.
Interdisciplinary data integration is an important development in modern biomedicine. The Entrez system of the National Center for Biotechnology Information (NCBI) is a well-known example. PubChem and MeSH (Medical Subject Headings) are good examples that link biological properties with information from other fields. PubChem aims to provide information on the biological activities of small molecules by including substance data, compound structures, and bioactivity data in 3 databases: PCSubstance, PCCompound, and PCBioAssay. MeSH is the National Library of Medicine's controlled vocabulary thesaurus. Integration of new sources by using these 4 databases and analytical data formed the immediate development of our system. The platform developed in this article shows the chemical components of herbs that modulate angiogenesis either individually or synergistically. The chemicals in our hierarchical structure can be further linked to the NCBI databases. In addition, it can be easily extended for visualization, retrieval, display, and analysis of associated analytical data (e.g., liquid chromatography/mass spectrometry, high-performance liquid chromatography, spectral analysis) on the action of these herbs by adding storage references to the tables and adjusting the Web display.
Rational primary screening to lead discovery
An essential component of drug discovery in TCM is determining the physiological and therapeutic effects of herbs. A single herb must contain at least 1 active ingredient to have medicinal value. The present data collected from primary screening aim to identify herbs containing angiogenic modulators and the component(s) contributing to the major bioactivity. Herbs and formulas that regulate blood and restore normal functioning and consistency of all exterior organs, Qi (energy), meridians, and blood were chosen for primary screening. This selection was based on the categories of CMM. 22 The process of identifying natural products and synthetic molecules as potential drug leads often involves testing large collections of compounds for their activities as inhibitors of activators of a specific biological target.
We have written software for a PDA that is capable of supporting a large volume of screening information and data (Fig. 4) . It provides a portable and standard platform for data input when performing screening experiments anywhere in the world. Our software can be readily modified for other kinds of bioassays or experiments, and central data can be accessed through the Internet. By using experimental and reference data in a database incorporating the 3 disciplines of CMM, plant classification, and chemistry, screening experiments may consume smaller quantities of compounds, take up less space, and be less expensive and time-consuming to conduct. In our study, we empirically selected herbs and formulas for screening based on TCM knowledge. Of these herbs and formulas, 11 herbs and 3 formulas showed antiangiogenic activities in the zebrafish embryos. With the help of the information in the database, the chemical compounds contained in those herbs could be selected for specific screening experiments. Therefore, the formulas, herbs, and compounds could be assayed in a single system to identify targets (hits) to serve as leads for further testing. Consequently, this will pave the way for supplementary means to drug discoveries in pharmaceutical research.
CONCLUSION
Our work consists of a database, handheld device software and data mining, and visualization tools. It provides a basis for retrieval of evidence-based data and guide for further research at the same time. Our system is expandable as the PDA software can be amended to fit the recording format required by different investigators. We also showed that phenotype-based screening in zebrafish provides an accessible method for the study of biological aberrations. We plan to commercialize and offer globally comprehensible tools by request, to assist in pharmacological research.
